Earnings History Data for Atossa Therapeutics, Inc. (ATOS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Atossa Therapeutics, Inc.
Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | ATOS | Atossa Therapeutics, Inc. | 188.64 | -0.05 | -0.05 | -0.05 | Atossa Therapeutics GAAP EPS of -$0.06 in-line [11/12/2024 8:36 AM] |
1.50 | -0.12 (-7.41%) |
1.58 | -0.04 (-2.46%) |
0.62 - 2.31 | 903,972 | 640,000 | 19,271 | ||
| 13-05-2024 | PM | ATOS | Atossa Genetics | 212.00 | -0.05 | -0.07 | 0.00 | Atossa Therapeutics GAAP EPS of -$0.05 [5/13/2024 10:05 AM] |
1.47 | -0.02 (-1.68%) |
0.0 | 0.0 (0.00%) |
0.62 - 2.31 | 1,377,795 | 1,430,000 | 0 | ||
| 01-04-2024 | AH | ATOS | Atossa Genetics | 226.00 | -0.06 | -0.05 | 0.00 | Atossa Therapeutics GAAP EPS of -$0.24 in-line [4/1/2024 4:41 PM] |
1.83 | -0.17 (-8.50%) |
2.03 | 0.03 (1.50%) |
0.59 - 2.11 | 3,369,512 | 3,160,000 | 91,639 | ||
| 14-08-2023 | PM | ATOS | Atossa Therapeutics, Inc. | 130.42 | -0.06 | 0.00 | -0.05 | Atossa Therapeutics GAAP EPS of -$0.08 misses by $0.02 [8/14/2023 8:58 AM] |
0.96 | -0.09 (-8.57%) |
1.01 | -0.04 (-3.81%) |
0.50 - 1.39 | 1,011,439 | 400,000 | 25,396 | ||
| 13-08-2021 | PM | ATOS | Atossa Therapeutics, Inc. | 397.51 | -0.06 | 0.00 | -0.43 | Atossa Therapeutics EPS misses by $0.02 [8/13/2021 9:35 AM] |
3.21 | -0.09 (-2.87%) |
3.36 | 0.05 (1.51%) |
0.81 - 9.80 | 5,579,514 | 12,310,000 | 54,765 | ||
| 31-03-2021 | PM | ATOS | Atossa Therapeutics, Inc. | 247.69 | -0.89 | 0.00 | -0.26 | Atossa Therapeutics EPS misses by $0.76 [3/31/2021 10:37 AM] |
2.15 | 0.05 (2.13%) |
2.10 | -0.01 (-0.47%) |
0.81 - 5.08 | 6,256,783 | 9,580,000 | 178,739 | ||